5-151829009-G-T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_StrongPP5_Very_Strong
The ENST00000274576.9(GLRA1):c.971C>A(p.Ser324Ter) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000136 in 1,614,016 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. S324S) has been classified as Likely benign.
Frequency
Consequence
ENST00000274576.9 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GLRA1 | NM_000171.4 | c.971C>A | p.Ser324Ter | stop_gained | 8/9 | ENST00000274576.9 | NP_000162.2 | |
GLRA1 | NM_001146040.2 | c.971C>A | p.Ser324Ter | stop_gained | 8/9 | NP_001139512.1 | ||
GLRA1 | NM_001292000.2 | c.722C>A | p.Ser241Ter | stop_gained | 7/8 | NP_001278929.1 | ||
GLRA1 | XM_047417105.1 | c.1019C>A | p.Ser340Ter | stop_gained | 8/9 | XP_047273061.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GLRA1 | ENST00000274576.9 | c.971C>A | p.Ser324Ter | stop_gained | 8/9 | 1 | NM_000171.4 | ENSP00000274576 | P4 | |
GLRA1 | ENST00000455880.2 | c.971C>A | p.Ser324Ter | stop_gained | 8/9 | 1 | ENSP00000411593 | A1 | ||
GLRA1 | ENST00000462581.6 | c.*729C>A | 3_prime_UTR_variant, NMD_transcript_variant | 7/8 | 1 | ENSP00000430595 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152246Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461770Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 10AN XY: 727178
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152246Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74374
ClinVar
Submissions by phenotype
Hyperekplexia 1 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | May 29, 2007 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 12, 2018 | The S324X nonsense variant in the GLRA1 gene has been reported previously (using S296X using alternative nomenclature) as a de novo change in an individual with hyperekplexia (Bellini et al., 2007). Functional studies demonstrated that S324X impairs protein function via a dominant negative effect (Bellini et al., 20017). This variant is not observed in large population cohorts (Lek et al., 2016). We interpret this variant as pathogenic. - |
Hereditary hyperekplexia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 01, 2022 | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this premature translational stop signal affects GLRA1 function (PMID: 17536053). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. ClinVar contains an entry for this variant (Variation ID: 16073). This premature translational stop signal has been observed in individual(s) with hyperekplexia (PMID: 17536053). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ser324*) in the GLRA1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 126 amino acid(s) of the GLRA1 protein. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at